fbpx

FAQ

Everything you need to know

If you are overwhelmed by the vast variety of CBD products, you are not alone. Each method delivers CBD to your body in a different way, which affects what it can be used for and how often you’ll want to take it. Enhancing this confusion is the fact that each of our bodies responds differently to cannabidiol (CBD), which means there is no one-size-fits-all recommendation. Each product has dosage instructions on its label. These dosages are a suggestion because every person is different. We suggest to start out with lower doses and build your way up until you find the perfect amount for the results you desire.

Yes, purchasing CBD is federally legal as long as it doesn’t contain more than 0.3 percent THC, but some state laws have put restrictions on purchasers. The Hemp Farming Act of 2018 was a proposed law to remove hemp (defined as cannabis with less than 0.3% THC) from Schedule I controlled substances and making it an ordinary agricultural commodity. Its provisions were incorporated in the 2018 United States farm bill that became law on December 20, 2018.

A Certificate of Analysis (COA) is a certificate that an independent 3rd party labratory has tested our oils and verified they are clean of foreign substances and contain a 0.3% or less THC level as well as the amount of Cannabidiol (CBD) in each batch and product line.

No. CBD will not give you the “high” that is produced from THC or the Marijuana plant.

Cannabidiol also known as CBD, is a phytocannabinoid discovered in 1940. It is one of 113 identified cannabinoids in cannabis plants and accounts for up to 40% of the plant’s extract. In 2018, clinical research on cannabidiol included preliminary studies of anxiety, cognition, movement disorders, and pain.

The term Full spectrum is when an oil contains all the cannabinoids that are found in the cannabis plant. This would include CBD (Cannabidiol) and all other properties in the plant with a 0.3% or less THC trace element.

The term Broad Spectrum is when an oil contains all the cannabinoids that are found in the cannabis plant. Then is gone through an additional process to remove the trace elements of THC. The negative of this process is that when the trace elements of THC is removed, so are some of the other benefits of the plant. 

To produce Isolate, CBD is isolated and then refined to strip out any additional cannabinoids, terpenes, and plant components found in the hemp plant. Isolates contain only one cannabinoid which is Cannabidiol (CBD) and 0% THC.

The endocannabinoid system (ECS) is a biological system composed of endocannabinoids, which are endogenous lipid-based retrograde neurotransmitters that bind to cannabinoid receptors, and cannabinoid receptor proteins that are expressed throughout the vertebrate central nervous system (including the brain) and peripheral nervous system. The endocannabinoid system remains under preliminary research, but may be involved in regulating physiological and cognitive processes, including fertility, pregnancy, during pre and post-natal development, appetite, pain-sensation, mood, memory, and in mediating the pharmacological effects of cannabis.

Two primary endocannabinoid receptors have been identified as CB1 and CB2. CB1 receptors are found predominantly in the brain and nervous system, as well as in peripheral organs and tissues, and are the main molecular target of the endocannabinoid ligand (binding molecule), anandamide, as well as its mimetic phytocannabinoid, THC. One other main endocannabinoid is 2-arachidonoylyglycerol (2-AG) which is active at both cannabinoid receptors, along with its own mimetic phytocannabinoid, CBD. 2-AG and CBD are involved in the regulation of appetite, immune system functions and pain management.

The cannabis plant and other plants produce cannabinoids, which interact with our body’s receptors. These plant cannabinoids are known as phyto-cannabinoids. Phyto is a prefix that means “pertaining to derived from plants”. They are categorized as any plant-derived natural product with the capability to directly interact with the body’s cannabinoid receptors or share chemical similarity with cannabinoids.

Furthermore, phytocannabinoids from cannabis have significantly influenced research on the endocannabinoid system. So far, they have become widely known for their medicinal properties in recent years. In particular, the cannabis plant contains over 400 chemical entities, and more than 60 of them are cannabinoid compounds, which have varying effects.

Cannabidiol – CBD | Cannabidivarin – CBDV | Cannabigerol – CBG | Tetrahydrocannabinol – THC | Tetrahydrocannabivarin – THCV | Cannabidiolic Acid – CBDA | Cannabichromene – CBC | Cannabinol – CBN | Tetrahydrocannabinolic Acid – THCA | Delta-9 Tetrahydrocannabinol – Δ9-THC

CB1 receptors are concentrated mostly in the brain and central nervous system. Cannabinoid receptor type 1, also known as cannabinoid receptor 1, is a G protein-coupled cannabinoid receptor that in humans is encoded by the CNR1 gene. The human CB₁ receptor is expressed in the peripheral nervous system and central nervous system.

CB2 receptors are concentrated mostly in the peripheral nervous system and immune system. The cannabinoid receptor type 2, abbreviated as CB2, is a G protein-coupled receptor from the cannabinoid receptor family that in humans is encoded by the CNR2 gene.

KEEP UP WITH US

Subscribe for special deals
and product updates!